Back to search

Article

Serum Levels of PSPH and CXCL2 as Predictors of Treatment Response in Male Patients with First-Episode Schizophrenia: A Single-Center Retrospective Study

2025-07-18

Abstract excerpt

<title>Abstract</title> <p> <bold>Objective</bold> To evaluate serum levels of Phosphoserine Phosphatase (PSPH) and Chemokine C-X-C Motif Ligand 2 (CXCL2) as biomarkers for predicting antipsychotic treatment response in male first-episode schizophrenia patients. <bold>Methods</bold> Bioinformatics analysis identified upregulated PSPH and CXCL2 expression in PBMCs of schizophrenia patients. Clinical data from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5181238c-61ab-5a1f-85ab-850827402f9b
DOI
10.21203/rs.3.rs-6877454/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum Levels of PSPH and CXCL2 as Predictors of Treatment Response in Male Patients with First-Episode Schizophrenia: A Single-Center Retrospective StudyDOI 10.21203/rs.3.rs-6877454/v1
Select a neighboring publication to make it the new centre.